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Abstract
Introduction: The Focal Infection Theory, originally presented at the beginning of the 20th century, postulates that
systemic diseases can be caused by microorganisms that arise from the focus of infection. Foci of infections have
been described as sinuses, adenoids, tonsils, teeth, genitourinary tract, gall bladder and kidneys. A focus of infec-
tion is defined as the area that can occur in any part of the body, contains a pathogen (microorganism) and is usu-
ally asymptomatic. There are discordant opinions about the role of focal infections in the pathogenesis of psoria-
sis and urticaria. 
Aim: To establish whether there is a higher incidence of focal infections in patients with chronic urticaria and pso-
riasis. 
Material and methods: We retrospectively reviewed 129 patients with a history of psoriasis and chronic urticaria:
58 women and 71 men treated in the Department of Dermatology of the Jagiellonian University Medical College in
Krakow. 
Results: In the analyzed group, 11 patients had a dental consultation, 58 – laryngological consultation and 29 women
had a gynecological consultation. The most common examples of focal infection were tonsillitis, upper respiratory
tract infections, sinusitis, dental caries and genitourinary tract infections. Aggravating factors were similar to pre-
viously described. 
Conclusions: A high incidence of focal infections in patients with psoriasis and urticaria suggests that infections may
play a significant role in the pathogenesis of these skin disorders. Treatment of infection foci may play the key role
in the remission of skin changes.
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Introduction
The Focal Infection Theory, originally presented at the
beginning of the 20th century, postulates that systemic dis-
eases can be caused by microorganisms that arise from the
focus of infection. Foci of infections have been described as
sinuses, adenoids, tonsils, teeth, genitourinary tract, gall blad-
der and kidneys. A focus of infection is defined as the area
that can occur in any part of the body, contains a pathogen
(microorganism) and is usually asymptomatic.
Chronic urticaria
Chronic urticaria is defined by the presence of urticaria,
on most days of the week, for at least 6 weeks. The diag-
nosis is made by description of its clinical features (typi-
cal urticarial lesions ± angioedema) with the criteria of time.
Approximately 40% of the patients with chronic urticaria
have episodes of angioedema [1]. Urticaria is classified into
immunological mediated (IgE-dependent and non-IgE
dependent) and non-immunological mediated ones. Phys-
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ical urticaria is caused by physical exertion, mechanical,
electromagnetic or thermal stimuli (such as water, UV light,
cold, heat, pressure) with nonspecific activation of mast
cells [2-4]. The most common form of chronic urticaria is
the idiopathic form (80-90%), where the external allergic
cause or disease cannot be found [5-7]. There are sever-
al theories trying to explain the pathogenesis of urticaria.
Chronic urticaria is usually self-limited with a duration of
2-5 years. Approximately 30-50% of patients with chron-
ic idiopathic urticaria have circulating auto antibodies to
the high-affinity IgE receptor, FcεRI, on the mast cells and
basophils releasing histamine or antibodies to IgE [8]. This
subgroup of chronic urticaria is called autoimmune
urticaria. The best in vivo clinical test for detection of in
vitro basophil histamine releasing activity with 65-71% sen-
sitivity and 78-81% specificity is the autologous serum skin
test (ASST) [9]. Skin lesions in urticaria are well-circum-
scribed, raised above the surface of the skin, pale in the
middle, with a smooth surface and extreme purities. 
The shape of the skin changes (plaques, wheals) varies:
they can appear as round, polycyclic, annular, geographic
lesions [10]. Angioedema in chronic urticaria is an episod-
ic swelling of the mucosa or subcutaneous tissue, asym-
metric, developing in a few minutes to a few hours, com-
mon in the area of the face [11]. Aggravating factors include
physical factors (hot, cold, humidity, etc.), NSAIDS, stress,
diet (e.g. spicy meals) [12, 13]. Many autoimmune disorders
are associated with chronic urticaria. Patients with chron-
ic urticaria have an increased odds ratio for hypothyroidism,
hyperthyroidism, antithyroid antibodies. There is a sig-
nificantly higher incidence of rheumatoid arthritis, Sjögren
syndrome, celiac disease, type I diabetes mellitus, and sys-
temic lupus erythematosus among female patients with
chronic urticaria. All examined patients had a high mean
platelet volume, positive rheumatoid factor, and antinu-
clear antibodies. The common mechanism in previously
mentioned diseases is a high prevalence of autoantibod-
ies and the presence of a chronic inflammatory process
(high mean platelet volume). 9.8% of examined patients
had hypothyroidism, 2.6% – hyperthyroidism (0.6% and
0.5%, respectively, in controls) [14]. Thyroid autoantibod-
ies (esp. anti-TPO antibodies, antimicrosomal antibodies)
are found 2-3 times more often among patients with chron-
ic urticaria than in controls [15, 16]. The exact role of autoan-
tibodies remains unknown. It is suggested that patients
with chronic urticaria have a higher tendency to develop
autoantibodies [17]. Focal bacterial, viral, parasite infections
may play the key role in autoimmunity. In the differential
diagnosis of the chronic urticaria, disorders that should be
taken into consideration are complement-mediated dis-
orders, malignancies, cutaneous or systemic mastocyto-
sis, connective tissue diseases (such as systemic lupus 
erythematosus, cutaneous blistering disorders (e.g. bul -
lous pemphigoid and dermatitis herpetiformis)) [18]. 
The pathogenesis of chronic urticaria has not been fully
described yet. The most popular theories include: the au -
t oimmune response, histamine releasing factors theory and
cellular defects theory. Autoimmune theory claims that
autoantibodies and serum factor present in blood cause
release of histamine from skin mast cells and basophiles.
The main argument against this theory is that antibodies
found in chronic urticaria (autoantibodies to IgE, FcεRI) are
not specific to the disease. The other theory is supported
by the fact that some patients with chronic idiopathic
urticaria demonstrate excessive production of platelet-
derived clotting factors. This could support the theory that
there are histamine releasing factors in the plasma. The
cellular defects theory claims that patients with urticaria
have mast cell defects (in signaling, trafficking, function)
[19-23].
Psoriasis
Psoriasis is a common and chronic inflammatory skin
disease with an incidence of 2.5% in Caucasians and 1.3%
in African-Americans [24, 25]. Psoriasis has high potential
to reduce the quality of life of the patient. Patients with
psoriasis reported reduction in physical functioning and
mental functioning comparable to patients with cancer,
arthritis, heart disease, hypertension, diabetes and depres-
sion [26]. Psoriasis is characterized by the presence of thick,
red skin with flaky, silver-white patches (scales) derived from
excessive growth of skin epithelial cells. In psoriasis we dis-
tinguish the following types: plaque (psoriasis vulgaris),
guttate, pustular, inverse (flexural psoriasis, intertriginous
psoriasis) and erythrodermic (exfoliative psoriasis) [27]. Pso-
riasis is characterized by flare-ups and remissions. Main
factors triggering psoriasis are: skin injuries (e.g. scratch-
ing), medications, stress, smoking, alcohol, streptococcal
infections, HIV and hormonal changes [28-31]. High pre -
valence of obesity has been reported in patients with pso-
riasis [32]. In differential diagnosis of psoriasis, the following
diseases should be considered: atopic keratoconjunctivi-
tis, atopic dermatitis, adult blepharitis, dry eye syndrome,
contact dermatitis, seborrheic dermatitis, diaper der-
matitis, onychomycosis, squamous cell carcinoma, num-
mular eczema, lichen planus, lichen simplex chronicus,
mycosis fungoides, subcorneal pustulosis, pustular erup-
tions pityriasis alba, pityriasis rosea, sicca keratocon-
junctivitis, syphilis, reactive arthritis, gout and pseudogout
and tinea [33]. Psoriasis is an autoimmune disease with
a great role of genetic and environmental factors in its
pathogenesis [34]. Factors playing a key role in the patho-
genesis of psoriasis are: T cells, antigen presenting cells
(APCs), keratinocytes, Langerhans’ cells, macrophages, nat-
ural killer cells (NKs), an array of Th1 type cytokines, growth
factors (VEGF, KGF) and others. The main hypothesis
assumes that the disease starts with the activation of the T
cell by an unknown antigen and subsequent secretion of
the cytokines by activated T cells, inflammatory cells and
keratinocytes. Activated Langerhans’ cells migrate to
lymph nodes and present the antigen to nodal naive T cells.
The T cells may become antigen-specific memory cells and
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may react with keratin (cross-reaction, molecular mimic-
ry). There are many studies supporting the role of genet-
ic factors in the pathogenesis of psoriasis. The concordance
rate for psoriasis is 63-73% in monozygotic twins, compared
to 17-20% in dizygotic twins. Loci suggested as predisposing
factors are PSORS1-PSORS9 [35]. The role of focal infections
in the pathogenesis of psoriasis has been described for
decades [36, 37]. There are single case reports of remission
of skin changes after tonsillectomy [38-44].
Focus of infection as the cause of systemic response
The Focal Infection Theory, with its simplicity, has been
the point of interest to scientists for decades. The first
description of focal infection influencing the whole organ-
ism was the cure of the arthritis in a patient after tooth
extraction, reported by Hippocrates. In 1890, doctor Miller
published his dissertation “The Micro-Organisms of the
Human Mouth: the Local and General Diseases Which are
Caused By Them”. Miller was the first scientist to use the
term “focal infection” [39, 40]. 1912 is the year of actual
beginning of the Focal Infection Theory. The physician Frank
Billings presented the theory in the form of case reports.
For the first time, he showed the role of tonsillectomy and
dental extractions in the cure of systemic diseases [41, 42].
The theory’s golden years were the twenties, when a large
number of diseases were treated with management of the
focal infection [43].
A systemic response may be caused by dissemination
of microorganisms from the focus. The possible role of foci
in the pathogenesis of systemic diseases has been attrib-
uted to inflammatory processes such as: arthritis, neu ritis,
endocarditis, pancreatitis, pneumonia, asthma, Hodgkin’s
disease etc. More recent studies mention among diseases
caused by microorganisms from focus of infection: sar-
coidosis, cancer, multiple sclerosis, amyotrophic lateral scle-
rosis, Guillain-Barre syndrome, autism, pediatric autoim-
mune neuropsychiatric disorders, Alzheimer’s disease,
Tourette’s syndrome, diabetes, obesity, cardiovascular dis-
ease, polycystic kidney disease, myasthenia gravis and sev-
eral skin conditions. Infections are one of the most com-
mon preventable causes of cancer [50].
Autoreactivity in chronic urticaria
Nearly one third of cases of spontaneous chronic
urticaria is caused by autoreactivity (30% of the patients
have positive autologous serum skin test). Autoimmuni-
ty occurs when the immune system of the host recognizes
and attacks its own tissues. There are many factors
responsible for the autoimmune response, such as genet-
ics, age and environment. Environmental factors trigger-
ing the development of the immune system response
include bacterial and viral infections [51]. In chronic
urticaria there is production of IgG antithyroid antibodies
and histamine releasing autoantibodies to the FcεRI
(high-affinity IgE receptor) or to IgE [52, 53]. The associa-
tion of HLA class II alleles, such as HLA-B44, DQB1*0302,
HLA-DRB1*01, HLA DRB1*04, HLA-DRB*15, confirms the
autoimmune theory of the pathogenesis of chronic
urticaria and may be the genetic factor in this process [54-
56]. Serum of the patients with the positive result of the
autologous serum skin test had significantly increased his-
tamine release compared with skin test-negative chron-
ic urticaria sera, as well as higher induction of basophile
CD63 surface expression and sulfidoleukotriene produc-
tion. Additionally, incubation with chloroquine, dapsone,
and lidocaine caused reduction in the histamine release,
CD63 expression, and sulfidoleukotriene production [57].
As a part of the Focal Infection Theory, host infection
by the pathogen (virus, bacteria) leads to autoimmunity.
If the pathogen carries amino acids similar to the self-anti-
gen, lymphocytes T or B are activated due to cross-reac-
tion and lead to the damage and activation of the other
parts of the immune system. This mechanism is called ‘mol-
ecular mimicry’. Persisting pathogens stimulate the
immune response and the lysis process, which leads to
release in antigens. Antigens from the damaged tissues
interact with antigen-presenting cells (APC) and cause self-
specific immune response. In the mechanism of ‘bystander
activation’, the inflammatory environment of the infection
activates one arm of the immune system, leading to the
domino effect with subsequent activation of the other
paths. The inflammatory process can also lead to processing
and presentation of ‘cryptic antigens’ normally invisible to
the immune system [57]. Several pathogens have been
described in the chronic urticaria, but only in Helicobac-
ter pylori, streptococcal, staphylococcal and Yersinia infec-
tions those mechanisms have been proved [58, 59].
A streptococcal infection is an example of molecular
mimicry between hemolytic streptococcus group A anti-
gens and proteins of the host. This leads to both humoral
and cell-mediated autoimmune reactions and clinical
consequences of rheumatic fever and heart disease [60].
The majority of the studies emphasize the role of Heli-
cobacter pylori as the exacerbating factor of the chronic
urticaria. The prevalence of Helicobacter pylori is higher
when an additional thyroid autoimmunity process occurs
[61]. Eradication of Helicobacter pylori causes often remis-
sion of chronic urticaria. Studies show that the remission
rate is 61.5% in patients with eradicated Helicobacter pylori
and 33.6% in the non-treated group. In 39% of patients per-
sistent yersiniosis was observed. Treatment with quinolones
led in some cases to remission of urticaria [62]. Norovirus
is a viral cause of urticaria [63]. The parasitic factors in chro -
nic urticaria include Blastocystis hominis, Giardia lamblia,
Trichinella, Trichomonas vaginalis and Toxocara canis
(35-46% of patients) [64-66]. 
Infections of oropharynx
Several studies show an increased incidence of ton-
sillitis, sinusitis and dental infections among patients with
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chronic urticaria. Wedi et al. found sinusitis in 32% of cas-
es of chronic urticaria and dental infections in 29% of the
patients [67]. Buss et al. found tonsillitis and sinusitis in
50% of patients [68]. In 10-42% of analyzed patients with
chronic urticaria, anti-streptococcal antibodies were
found. Ten percent of the patients had anti staphylolysin
antibodies [57]. Buchter et al. and Goga et al. did not find
a significant increase of oropharyngeal infections (tonsil-
litis, sinusitis, caries, periodontitis, periapical lesions,
and nonvital and missing teeth) in patients with chronic
urticaria. There have been single cases of the recurrence
of chronic urticaria after antibiotic treatment [57].
Aim 
There are discordant opinions about the role of focal
infections in the pathogenesis of psoriasis and urticaria.
The aim of the study was to establish whether there is
a higher incidence of focal infections in patients with chron-
ic urticaria and psoriasis.
Material and methods
We retrospectively reviewed 129 patients with a his-
tory of psoriasis and chronic urticaria: 58 women and 
71 men treated in the Department of Dermatology of the
Jagiellonian University Medical College in Krakow. We col-
lected the following data: patients’ age, sex, diagnosis (type
of psoriasis, urticaria), aggravating factors, type of con-
sultation (gynecological, dental, laryngological) with its
result and C-reactive protein (CRP) value (as the marker
of the inflammatory process). We examined 101 patients
with psoriasis: 77 patients had plaque psoriasis, 16 had pso-
riatic arthritis, 4 presented with pustular psoriasis, 4 with
psoriatic erythroderma and 28 patients had chronic
urticaria. The median age of the patients was 47.91 years
with the youngest aged 19 and the oldest 87. 
Results
In the analyzed group, 11 patients had a dental con-
sultation, 58 – laryngological consultation and 29 women
had a gynecological consultation. 
Psoriasis (men and women)
The medium age of patients with psoriasis was 48.49 years
(19-87 years). Seventy-seven patients had plaque psoriasis,
16 presented with psoriatic arthritis, 4 with pustular psoria-
sis and 4 with psoriatic erythroderma. In different types of pso-
riasis, the percentage of women and men was as follows:
• plaque psoriasis: 23 women (29.87%), 54 men (70.13%),
• psoriatic arthritis: 7 women (43.75%), 9 men (56.25%),
• pustular psoriasis: 3 women (75%), 1 man (5%),
• psoriatic erythroderma: 1 woman (25%), 3 men (75%) (Fig-
ure 1).
Forty-two patients had a consultation with a laryn-
gologist (29 with plaque psoriasis, 9 with psoriatic arthri-
tis, 2 with pustular psoriasis and 2 with psoriatic ery-
throderma), 9 patients had a dental consultation and 
16 women were consulted by a gynecologist.
In the studied group, 24 patients had a laryngological
disorder. Among patients with plaque psoriasis 12 had
a laryngological focus of infection (41.38% of the patients
with plaque psoriasis). A laryngological source of infection
was found in 7 patients with psoriatic arthritis (43.75%),
1 with pustular psoriasis (25%) and 2 with psoriatic ery-
throderma (50%). Eight patients (7.92%) had a dental focus
of infection.
Women with psoriasis 
Among 34 women with psoriasis, 23 had plaque pso-
riasis (68% of women), 7 had psoriatic arthritis, (20%), 
3 women had pustule psoriasis (9%) and 1 woman had pso-
riatic erythroderma (3%) (Figure 2).
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Figure 1. Focal infections (laryngological) in patients with
psoriasis
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In the group of women with psoriasis, 16 patients had
a laryngological consultation, 16 women had a gynecological
consultation and 3 – a dental consultation. Ten women had
laryngological diagnosis (29.41% of women), 4 women had
gynecological diagnosis (11.76%) and 3 had dental diag-
nosis (8.82%). Thirteen women had at least one focus of
infection (38.24% of women). Four women had 2 foci of
infection. The numbers of patients with laryngological and
gynecological consultations are shown in Figures 3 and 4. 
Men with psoriasis
Among men with psoriasis, median age was 47.99 years
old (19-86) (Figure 5). Fifty-four men (81%) had plaque pso-
riasis, 9 men had psoriatic arthritis (13%), 1 man had pus-
tular psoriasis (2%) and 3 patients had psoriatic erythro-
derma (4%). Twenty-five patients were consulted laryn-
gologically and 6 had a dental consultation. Five patients
had a dental inflammatory process (4 patients with
plaque psoriasis and 1 patient with psoriatic arthritis). Four
patients (5.97% of male patients with psoriasis) had a den-
tal focus of infection, 13 patients had laryngological diag-
nosis (19.4%). Nineteen male patients with psoriasis
(28.36%) had a focus of infection localized in the orophar-
ynx. None of the patients had more than one focus of infec-
tion (Figure 6). 
Patients with urticaria (men and women)
We examined 28 patients with urticaria, 4 men and 
24 women. The medium age of the analyzed group was 45.86
(patients aged: 22-77). Sixteen patients were consulted by
Figure 5. Men with psoriasis
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Figure 3. Foci of infection (laryngological) in women with
different types of psoriasis
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Figure 4. Foci of infection (gynecological) in women with
different types of psoriasis
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a laryngologist, 13 women by a gynecologist, and 3 patients
by a dentist. Three patients (10.71%) had a focus of infec-
tion localized in the dental area, 8 patients (28.57%) – in sinus-
es and the respiratory tract (laryngological diagnosis),
1 woman had a focus of infection localized in the urogeni-
tal tract (3.57% of all patients). Among them, 2 patients had
2 foci of infection. Ten of 28 patients with urticaria (35.71%)
had at least one type of focus of infection. All the cases of
focal infections among patients with urticaria appeared in
women. 
C-reactive protein values
Medium CRP value in the patients with psoriasis was
12,714 mg/l and 5.4 mg/l in the patients with hives.
Aggravating factors in psoriasis and urticaria
Among patients with urticaria, 11 patients (39.29%) report-
ed factors aggravating the symptoms of urticaria. The wors-
ening of the clinical status of patients was observed after
exposure to drugs (3 patients), particular food (3 patients),
stress (3 patients), physical factors (1 patient) and plants 
(1 patient). Among patients with psoriasis, the influence of
the exogenous factor was observed in 17 patients (16.83%).
Two patients reported aggravation of skin changes after drug
administration, one after particular food, 5 after exposure
to stressful situations, 5 caused by physical factors, 4 report-
ed other factors, but could not determine them. 
Types of focal infections
In patients with urticaria, the most common laryngo-
logical sources of infection were sinusitis with nasal sep-
tum deformity (8 patients), upper respiratory tract infec-
tion (3) and tonsillitis (2). Among gynecological causes, 
2 changes were localized in the uterus, 2 – in the cervix,
one in the vagina (bacterial vaginosis). One patient had
a deep carious lesion. Among patients with psoriasis, 
10 had tonsillitis, 9 – upper respiratory tract infection, 
5 – sinusitis with nasal septum defect, 2 – nasal polyps and
2 – otitis. Dental foci of infection were deep carious lesions
(10). Gynecological sources of infection were cervical (3),
vaginal (1) and ovarian (1). 
Discussion
The analysis of data obtained from the patients’ doc-
umentation provides statistical information on the inci-
dence of psoriasis and urticaria among adults in the region
of Krakow. The most common type of psoriasis is plaque
psoriasis, followed by psoriatic arthritis, pustular psoria-
sis and rare psoriatic erythroderma. The majority of the
patients with psoriasis were male, with 70.13% of male
patients with plaque psoriasis, 56.25% with psoriatic arthri-
tis, 25% with pustular psoriasis and 75% with psoriatic ery-
throderma. There was a significantly higher incidence 
of plaque psoriasis in men (81%) than in women (68%). 
The incidence of focal infection was higher in women
(38.24%) vs. 28.36% in men. A lower statistical incidence
of infections may be caused by additional gynecological
examinations in women. In this retrospective study, the uro-
logical consultation was not included. We assume that the
percentage of focal infections would be higher in men. if
the patients were consulted by an urologist. Among
patients with urticaria, 35.71% of patients had a focus of
infection, which confirms results presented in the previ-
ous studies concerning this topic. Wedi et al. found
sinusitis in 32% of cases of chronic urticaria and 29% of
dental infection cases [67]. In 10-42% of patients with chron-
ic urticaria, anti-streptococcal antibodies were found
[68]. Patients with psoriasis had a higher CRP level (result
above the reference range) in comparison to patients with
urticaria (result within the reference range). The most com-
mon examples of focal infection were tonsillitis, upper res-
piratory tract infections, sinusitis, dental caries and gen-
itourinary tract infections. Aggravating factors were
similar to previously described ones.
Conclusions
A high incidence of focal infections in patients with pso-
riasis and urticaria suggests that infections may play a sig-
nificant role in pathogenesis of these skin disorders.
Treatment of infection foci may play a key role in the remis-
sion of skin changes. 
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